|
|
|
|
|
Sequenom Q4 Loss Widens - Update
- 9 Hours ago
|
|
|
|
3/15/2010 5:35 PM ET RELATED NEWS Trade SQNM now with TOP MARKET NEWS (RTTNews) - Life science company Sequenom, Inc. (SQNM: News ), Monday reported a fourth quarter loss that widened from last year,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Genzyme inspection finds drug impurity
- 66 Minutes ago
|
|
|
|
Genzyme Corp. has notified its customers that an impurity has been found in one vial of the drug Cerezyme at its plant in Waterford, Ireland, in what is the latest in a series of manufacturing problems
|
|
|
|
|
|
|
|
|
|
|
|
|
Tapping RNA silencing pathways for plant biotechnology
- 3 Hours ago
|
|
|
|
Plants have evolved a variety of gene silencing pathways mediated by small RNAs. Mostly 21 or 24 nt in size, these small RNAs repress the expression of sequence homologous genes at the transcriptional,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sequenom Inc. Q4 2009 Earnings Call Transcript
- 8 Hours ago
|
|
|
|
4:30 pm ET Executives Ian Clements â?? Senior Director, IR and Corporate Communications Harry Hixson â?? Chairman and CEO Paul Maier â?? Interim CFO Analysts Zarak Khurshid â?? Wedbush Securities Evan
|
|
|
|
|
|
|
|
|
|
|
|
|
Maryland May Mandate Biotech Investment
- 9 Hours ago
|
|
|
|
A new Maryland state law may require the Maryland State Retirement and Pension System to invest nearly 50 million in bioscience and medical technology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Satcon Appoints Chief Financial Officer
- 5 Hours ago
|
|
|
|
BOSTON--(BUSINESS WIRE)--Satcon Technology Corporation (NASDAQ CM: SATC), a leading provider of utility scale power solutions for the renewable energy market, today announced the appointment of Donald
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sequenom cites progress on problems with key test
- 3 Hours ago
|
|
|
|
Sequenom said it made significant progress during the fourth quarter in addressing problems related to the mishandling of data for a key Down syndrome test. The San Diego biotechnology company said it
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BioTech Capital buys back 15k shares
- 3 Hours ago
|
|
|
|
Source: News Bites BioTech Capital Ltd bought back 15,000 shares for $3,150 on-market on March 15, 2010. Previously 3,394,526 shares have been bought back. There are 4,570,951 shares still to be bought
|
|
|
|
|
|
|
|
|
|
|
|
|
Bulgaria Food Products Show High Levels of GMOs
- 5 Hours ago
|
|
|
|
A higher level of GMOs than the allowed limit was found in 7% of the food products tested by the Sofia public health body RIOKOZ in 2009. A high content of GMOs was found predominantly in sausages, wafers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Decoded Genome Gives New Hope in Confronting Diseases
- 5 Hours ago
|
|
|
|
Two research teams have independently decoded the entire genome of patients to find the exact genetic cause of their disease. The approach may offer a new start in the so far disappointing effort to identify
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cephalon Patent Suit Over Amrix Survives Dismissal
- 6 Hours ago
|
|
|
|
A federal judge has ruled that a patent infringement suit against Anchen Pharmaceuticals Inc. over its plans to make a generic version of Cephalon Inc. muscle relaxant Amrix can go forward, largely denying
|
|
|
|
|
|
|
|
|
|
|
|
|
The sexual tug-of-war -- a genomic view
- 6 Hours ago
|
|
|
|
ScienceDaily (Mar. 15, 2010) â?? The genes that are most beneficial to males are the most disadvantageous for females, and vice versa. However, this genetic conflict between the sexes is important in
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Votes may take up to 30 minutes to influence
article rank order |
|